Filing Details
- Accession Number:
- 0001562180-23-002489
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-06 16:37:48
- Reporting Period:
- 2023-03-02
- Accepted Time:
- 2023-03-06 16:37:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1645113 | Novocure Ltd | NVCR | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1822879 | X Frank Leonard | C/O Novocure Inc. 1550 Liberty Ridge Drive, Suite 115 Wayne PA 19087 | President, Cns Cancers Us | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2023-03-02 | 844 | $75.28 | 58,144 | No | 4 | S | Direct | |
Ordinary Shares | Acquisiton | 2023-03-03 | 11,808 | $0.00 | 69,952 | No | 4 | A | Direct | |
Ordinary Shares | Disposition | 2023-03-03 | 2,059 | $77.64 | 67,893 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- Represents vesting of performance-based restricted stock units.
- Sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.